Results 21 to 30 of about 32,303 (159)
Frontiers in Cellular and Infection Microbiology, 2023 Psittacosis and Guillain-Barré syndrome are both rare clinical diseases with low incidence, and their combination has rarely been reported. Here, we report a case of Chlamydia psittaci pneumonia combined with Guillain-Barré syndrome.
Changquan Fang +5 more
doaj +1 more source
Guillain–Barre syndrome after myocardial infarction: a case report and literature review
BMC Cardiovascular Disorders, 2023 Background Guillain–Barre syndrome after myocardial infarction occurs infrequently, and its occurrence following percutaneous coronary intervention is extremely rare.
Pu-yuan Wen +5 more
doaj +1 more source
Intact thumb reflex in areflexic Guillain Barré syndrome: A novel phenomenon
Annals of Indian Academy of Neurology, 2014 Introduction: Areflexia is one of the cardinal clinical features for the diagnosis of Guillain Barré syndrome. However, some patients may have sluggish proximal muscle stretch reflexes.
Karkal Ravishankar Naik +2 more
doaj +1 more source
Case Reports in Transplantation, 2017 Guillain-Barré Syndrome (GBS) is a common acute autoimmune polyneuropathy in adults. There have been few reported cases of Guillain-Barré Syndrome associated with active cytomegalovirus (CMV) infection in renal transplant recipients.
Massini Merzkani +2 more
doaj +1 more source
Plasmaferesis Sebagai Terapi Sindrom Guillain-Barre Berat pada Anak
Sari Pediatri, 2016 Plasmaferesis atau plasma exchange merupakan salah satu pilihan terapi bagi sindrom Guillain-Barre berat. Beberapa penelitian menunjukkan bahwa plasmaferesis dan imunoglobulin intravena (IVIg) sebagai terapi sindrom Guillain-Barre memiliki efektivitas ...
Vimaladewi Lukito +3 more
doaj +1 more source
Therapeutic Apheresis and Dialysis, EarlyView.ABSTRACT Background Establishing a comprehensive apheresis medicine program in a resource‐constrained setting presents significant structural, financial, and logistical challenges. Despite the growing clinical importance of apheresis services globally, published experience from sub‐Saharan Africa remains sparse.
Folasade Adelekan‐Popoola +4 more
wiley +1 more source
British Journal of Clinical Pharmacology, EarlyView.Aim Novel oral polio vaccine type 2 (nOPV2) was used under the WHO emergency use listing for circulating vaccine‐derived polio virus (cVDPV) outbreaks from 2021 to 2023. We assessed nOPV2 adverse events following immunization (AEFIs) and compared its safety profile to other vaccines using VigiBase.
Comfort Kunak Ogar +6 more
wiley +1 more source
Guillain-Barre Syndrome Following Ad26.Cov2.S Covid-19 Vaccine: A Case Report
Journal of Nobel Medical College, 2021 Guillain-Barre Syndrome has been reported as a rare side effect in the recipients of Johnson & Johnson®'s Janssen Ad26.COV2.S COVID-19 vaccine. We report a case of Guillain-Barre Syndrome in a 50 years old female following the administration of the ...
Sushmita Khanal, Sunil Babu Khanal
doaj +1 more source
Clinical Pharmacology &Therapeutics, EarlyView.Postmarketing safety surveillance data identify safety issues not identified in preapproval clinical trials. We describe the frequency of new safety issues overall and by labeling section and the relationship of the most commonly added safety issues with the cumulative number of prescriptions dispensed via retail pharmacies.
Ellen Pinnow +14 more
wiley +1 more source
Guillain–Barré syndrome variants: a grave complication of bariatric surgery
The Egyptian Journal of Neurology, Psychiatry and Neurosurgery, 2022 Background Guillain–Barré syndrome is an acquired inflammatory disease of the peripheral nervous system. It is the most frequent cause of acute flaccid symmetrical weakness of the limbs and areflexia usually reaching its peak within a month.
Raseel A. Aljthalin, Alawi A. Al-Attas
doaj +1 more source